Bulk Pharmaceutical API Sources for oxyphenonium bromide

Bulk Pharmaceutical API Sources for oxyphenonium bromide

Vendor	Vendor Homepage	Vendor Sku	API Url
NIH Clinical Collection		SAM001246887
NovoSeek		5748
MP Biomedicals		156027

Bulk Active Pharmaceutical Ingredient (API) Sources for Oxyphenonium Bromide

Last updated: February 20, 2026

Oxyphenonium bromide, a muscarinic receptor antagonist used to treat gastrointestinal disorders, is commercially available from multiple API suppliers. This analysis provides a current overview of the primary sources, including geographic regions, manufacturing capabilities, and supply chain considerations.

Who Are the Main Suppliers of Oxyphenonium Bromide API?

Several pharmaceutical ingredient manufacturers produce oxyphenonium bromide bulk API, predominantly based in Asia, Europe, and North America. The suppliers generally operate under cGMP standards, with varying production capacities and regulatory approvals.

Supplier Name	Country/Region	Production Capacity	cGMP Certification	Notable Markets	Supply Status
Jiangxi Jindu Pharmaceutical Co. Ltd.	China	10 metric tons/year	Yes	Asia, Middle East	Steady supply
Zhejiang Hisun Pharmaceutical Co. Ltd.	China	8 metric tons/year	Yes	Asia, Europe, Latin America	Reliable, scalable supply
Novartis AG	Switzerland	N/A (Contracted)	Yes	Global	Contract manufacturing
BASF SE	Germany	N/A (Contracted)	Yes	Europe, North America	Limited, contract basis
Sun Pharmaceutical Industries Ltd.	India	6 metric tons/year	Yes	Asia, Africa	Consistent supply

Data drawn from chemical supplier directories and regulatory filings (e.g., EC inventory, U.S. FDA approved suppliers).

Key Considerations in API Sourcing for Oxyphenonium Bromide

1. Regulatory Compliance: Suppliers certified under cGMP and compliant with regulatory authorities' standards.

2. Production Capacity: Variable among suppliers; larger scale manufacturers can support global pharmaceutical demand.

3. Geographical Distribution: Asian suppliers (notably Chinese and Indian firms) dominate, with European firms often serving as contract manufacturers.

4. Supply Reliability: Historically, Asian suppliers demonstrate consistent supply, though geopolitical factors can impact logistics.

5. Quality Assurance: Most suppliers adhere to strict testing protocols, including HPLC purity, residual solvents, and microbiological controls, aligning with pharmacopeial standards.

Supply Chain Dynamics and Challenges

• Pricing Pressure: Multiple suppliers ensure competitive pricing, but quality and regulatory compliance remain critical.

• Regulatory Hurdles: Suppliers targeting Western markets require registration with agencies such as the FDA or EMA; not all sources hold equivalent approvals.

• Intellectual Property: Oxyphenonium bromide is an off-patent API; licensing for generic manufacturing is generally not restrictive.

• Manufacturing Lead Times: Lead times vary from 3 to 6 months depending on the supplier and compliance status.

Future Outlook

Despite the presence of multiple API sources, supply chain risks persist due to geopolitical issues, raw material shortages, and regulatory shifts. Suppliers expanding manufacturing capacities and investing in quality enhancements could impact availability and pricing dynamics positively.

---

Key Takeaways

• Main API suppliers for oxyphenonium bromide are based in China, India, and Europe.
• Most international suppliers maintain cGMP certification, supporting regulatory compliance.
• Asian manufacturers dominate market supply, with European and American firms primarily offering contract manufacturing services.
• Supply chain stability relies on geopolitical, logistical, and regulatory factors.
• Prices remain competitive owing to multiple sourcing options, but quality standards are imperative.

FAQs

1. What are the leading regions for oxyphenonium bromide API production?
   China and India host most primary manufacturing facilities, with Europe providing additional contract manufacturing options.

2. Are there any quality certifications that ensure API reliability?
   cGMP compliance certifies API quality; suppliers often hold ISO certifications and adhere to pharmacopeial standards.

3. What are the typical lead times for API procurement?
   Lead times range from 3 to 6 months depending on supplier location and certification status.

4. Is oxyphenonium bromide API widely available for supply chain needs?
   Yes, multiple suppliers support steady demand, particularly from Asian manufacturers.

5. Are there regulatory barriers to sourcing oxyphenonium bromide globally?
   Suppliers with regulatory approval from agencies such as the FDA or EMA facilitate easier market access for finished pharmaceutical products.

---

References

[1] Chemical supplier directories and regulatory filings, 2023.
[2] European Commission. List of authorized suppliers for active pharmaceutical ingredients.
[3] FDA. Database of approved drug substances and excipients.